Working… Menu

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04273646
Recruitment Status : Not yet recruiting
First Posted : February 18, 2020
Last Update Posted : April 14, 2020
Wuhan Hamilton Bio-technology Co., Ltd, China.
Information provided by (Responsible Party):
Yang Jin, Wuhan Union Hospital, China

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : February 15, 2022